This study evaluates early interventions in prediabetic individuals. One group receives standard ICMR care, while the other adds continuous biofeedback tools for BIA, glucose monitoring, and calorie tracking. Clinical and biological data including genetics, metabolism, and gut microbiome are collected at baseline, every six months, and at study end over two years. The primary goal is to assess how biofeedback influences blood sugar and weight, with secondary insights into how commonly available biofeedback tools reflect underlying biology through multi-omics assessments.